In 2022, there were nearly 1.5 million cases of prostate cancer, but only 400,000 deaths. Low-grade prostate cancer, commonly known as GG1 among physicians, virtually never metastasizes or causes ...

Bayer (OTCPK:BAYZF) on Wednesday announced plans to seek an expanded label for its prostate cancer therapy Nubeqa (darolutamide) after the oral androgen receptor inhibitor (ARi) as part of ...

With the Optilume BPH catheter system, urologists inflate a balloon to split the lobes of the prostate. A second balloon can further separate the lobes and deliver a drug, paclitaxel ― best ...

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...